of the Flag-tagged TRAIL receptors revealed that FADD associated with both TRAIL-R1 and TRAIL-R2 ( Figure  3A ), although the association was weaker than that observed in parallel experiments using the Flag-tagged cytoplasmic region of Fas (data not shown). In addition to FADD, TRADD was detected in these immunoprecipitates. However, TRADD binding was not observed in the absence of coexpressed FADD, indicating that the association of TRAIL-R1 and TRAIL-R2 with TRADD may be mediated by FADD or may be dependent on the presence of FADD in the signaling complex. Similar results were obtained when the association of full-length TRAIL-R1 with FADD and TRADD was investigated (Figure 3B) .
TRAIL-R1 and TRAIL-R2 Activate NF-B
TRADD is an essential adaptor protein in the signal cas- 4). An increase in luciferase activity of up to 10-fold was measured, comparable to levels induced by TRAMP (Bodmer et al., 1997) . cellular FLIP (FLIPL, which blocks FLICE recruitment and activation) (Irmler et al., 1997; Thome et al., 1997) and Several lines of evidence indicate that FADD plays an essential role in the death-inducing signaling complex a FADD dominant negative version of the protein (FADD-DN, lacking the death effector domain) all reduced of TRAIL receptors. First, FADD-DN inhibits TRAILinduced cell death in three different cell lines: BJAB, apoptosis mediated by both TRAIL-R1 and TRAIL-R2 ( Figure 2A ). We conclude that the apoptotic signaling 293T, and CV-1 (Walczak et al., 1997) ; second, Jurkat cell lines expressing FLIP of viral or cellular origin become pathways of the two receptors are similar and involve the intracellular proteins FADD and FLICE (caspase 8 resistant to TRAIL-mediated apoptosis (Irmler et al., 1997; Thome et al., 1997) ; and third, FADD coimmunoor caspase 10).
To corroborate our findings, we investigated signaling precipitates with TRAIL-R1 and TRAIL-R2. Our results are in agreement with a report published while this in cells that had been stably transfected with TRAIL-R1 ( Figure 2B ). In contrast to the parental cell line, which manuscript was under revision (Walczak et al., 1997) but do not support previous findings that TRAIL-R1 does shows little sensitivity to TRAIL despite the presence of TRAIL-R2 mRNA ( Figure 2C ), TRAIL-R1-transfected not associate with FADD (Marsters et al., 1996a; Pan et al., 1997a Pan et al., , 1997b Sheridan et al., 1997) . This discrep-293T cells ( Figure 2C ) are susceptible to TRAIL. When these cells were transfected with a FADD-DN expression ancy is probably due to differences in the experimental conditions used. vector, cells no longer responded to TRAIL, indicating that TRAIL-R1 signals triggered by the natural ligand TRAIL-R1 and TRAIL-R2 trigger at least two distinct signaling pathways, leading either to death or to NF-B are also FADD dependent. An essential role for FADD in TRAIL signaling was further supported by the obseractivation. In this respect, signals induced by TRAIL-R1 and TRAIL-R2 are similar to that induced by TNFR1 and vation that the stable expression of FADD-DN in the B lymphoma line BJAB rendered these cells insensitive to TRAMP: all four receptors recruit FADD and TRADD upon overexpression, albeit with different efficiencies. both TRAIL-and FasL-mediated killing ( Figure 2D ). The BJAB line expresses both TRAIL-R1 and TRAIL-R2 However, the TRAIL receptors recruit these adaptors not very efficiently, suggesting that binding may be indimRNA ( Figure 2C ), but only TRAIL-R2 mRNA was detected in TRAIL-sensitive Jurkat cells, which are renrect and possibly mediated by yet an additional adaptor protein. Moreover, the molecular ordering of the adaptor dered insensitive to TRAIL by viral and cellular FLIP (Irmler et al., 1997; Thome et al., 1997 ).
proteins appears to be different. Whereas TRADD is upstream of FADD in the TNFR1 and TRAMP signaling, These results suggest that FADD is a constituent of both TRAIL-R1 and TRAIL-R2 signaling complexes. To the converse is observed in the TRAIL-R1 and TRAIL-R2 signaling pathways. It will be useful to determine analyze whether a physical association of FADD with the receptors does indeed occur, Flag-tagged cytoplasmic how this difference influences the receptors' decision either to activate NF-B or to initiate the cell death TRAIL-R1 or TRAIL-R2 were cotransfected with FADD expression vectors in 293T cells. Immunoprecipitation program. plasmid was added when necessary to keep the total amount of Flag-tagged recombinant soluble human FasL and TRAIL were plasmid constant. Thirty to 36 hr after transfection, cells were lysed used as described (Schneider et al., 1997a; Thome et al., 1997) .
in 250 l of lysis buffer (1% Nonidet P-40, 20 mM Tris-HCl [pH Monoclonal antibodies (MAbs) used for immunoprecipitation and 7.4], 150 mM NaCl) supplemented with complete protease inhibitor Western blotting included an anti-Flag M2 antibody and anti-Flag cocktail (Boehringer Mannheim). Postnuclear lysates were pre-M2 agarose (Kodak International Biotechnologies), an anti-FADD cleared for at least 1 hr on Sepharose 6B (Pharmacia) before precipiantibody (Transduction Laboratories), and an antibody against the tation for 2 hr or overnight with 3 l of anti-Flag agarose. Precipitates Myc epitope (9E10).
were washed twice with lysis buffer and twice in lysis buffer conThe full-length TRAIL receptors have been described previously taining 0.1% Nonidet P-40; boiled in sample buffer; and analyzed (Schneider et al., 1997b) . The cytoplasmic domains of TRAIL-R1
by SDS-polyacrylamide gel electrophoresis and Western blotting (amino acids 261-465) and TRAIL-R2 (amino acids 232-439) were onto nitrocellulose (Hybond ECL, Amersham). Blots were saturated amplified by polymerase chain reaction (PCR) using the proofreading Pwo polymerase (Boehringer, Mannheim) and were subcloned with 5% skim milk, 0.5% Tween-20 in phosphate-buffered saline, Thirty-two hours after transfection the extent of cell death was asat 1 g/ml, or anti-Myc MAb (9E10) at 2 g/ml, followed by incubation with peroxidase-conjugated secondary antibody (Jackson Labsessed by morphological inspection of the cells by phase contrast microscopy, and nuclear DNA degradation was determined in cell oratories). Bound antibodies were detected using the enhanced chemiluminescence kit (Amersham International) according to the lysates using a kit from Boehringer (no. 1544 675) that detects cytoplasmic histone-associated DNA fragments. manufacturer's instructions.
BJAB cells (100 l, 50,000 cells, in 96-well plates) were incubated at 37ЊC in the presence of soluble FasL or soluble TRAIL at the Cell Death and Cell Proliferation Assays 293T cells (2 ϫ 10 5 ) (wild-type or stably expressing TRAIL-R1) were indicated concentrations and 1 g/ml of M2 MAb. After 16 hr, 20 l of a solution containing 2 mg/ml 3-(4,5-dimethylthiazol-2-yl)-5-transiently transfected in 6 cm plates with 2 g of pCRIII expression vector encoding full-length TRAIL-R1, -R2, or -R3, together with (3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tertrazolium, inner salt (MTS) reagent (Promega) and 50 g/ml phenazine methosulfate expression vectors for v-FLIP (E8 of EHV-2, 0.5 g) (Thome et al., 1997) , human FLIP L (0.1 g) (Irmler et al., 1997), or FADD-DN (2 g) was added to the cells. Following color development (3 hr), absorbance at 490 nm was measured with an enzyme-linked immunoand irrelevant plasmid to keep the total amount of plasmid constant. Cells were washed and the caspase inhibitor z-VAD-fmk was added, sorbent assay reader. Apo-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588.
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